Evidence map›Paper›PMID 26192076›Full record

ArticleScientific reports2015

Impaired formation of homotypic cell-in-cell structures in human tumor cells lacking alpha-catenin expression.

Manna Wang, Xiangkai Ning, Ang Chen, Hongyan Huang, Chao Ni, Changxi Zhou, Kaitao Yu, Sanchun Lan, Qiwei Wang, Shichong Li and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Manna Wang1] Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China [2] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Xiangkai Ning1] Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China [2] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Ang ChenLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Hongyan Huang1] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [2] Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing 100038, P. R. China.
Chao NiThe Institute of Life Sciences, the State Key Laboratory of Kidney; the Key Laboratory of Normal Aging &Geriatric, the Chinese PLA General Hospital, Beijing 100853, P. R. China.
Changxi ZhouThe Institute of Life Sciences, the State Key Laboratory of Kidney; the Key Laboratory of Normal Aging &Geriatric, the Chinese PLA General Hospital, Beijing 100853, P. R. China.
Kaitao YuDepartment of Stomatology, Affiliated Hospital of Academy of Military Medical Science, 8 Dongda Street, Beijing 100071, P. R. China.
Sanchun LanDepartment of Stomatology, Affiliated Hospital of Academy of Military Medical Science, 8 Dongda Street, Beijing 100071, P. R. China.
Qiwei WangLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Shichong LiLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Hong LiuLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Xiaoning WangThe Institute of Life Sciences, the State Key Laboratory of Kidney; the Key Laboratory of Normal Aging &Geriatric, the Chinese PLA General Hospital, Beijing 100853, P. R. China.
Zhaolie ChenLaboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China.
Li MaInstitute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China.
Qiang Sun1] Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P. R. China [2] National Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, P. R. China.
Institute of Life Sciences · INSouthern Medical University · CNAcademy of Military Medical Sciences · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although cell-in-cell structures (CICs) could be detected in a wide range of human tumors, homotypic CICs formed between tumor cells occur at low rate for most of them. We recently reported that tumor cells lacking expression of E- and P-cadherin were incapable of forming homotypic CICs by entosis, and re-expression of E- or P-cadherin was sufficient to induce CICs formation in these tumor cells. In this work, we found that homotypic CICs formation was impaired in some tumor cells expressing high level of E-cadherin due to loss expression of alpha-catenin (α-catenin), a molecular linker between cadherin-mediated adherens junctions and F-actin. Expression of α-catenin in these tumor cells restored cell-cell adhesion and promoted CICs formation in a ROCK kinase-dependent way. Thus, our work identified α-catenin as another molecule in addition to E- and P-cadherin that were targeted to inactivate homotypic CICs formation in human tumor cells.

Indexed as

ActinsAdherens Junctionsalpha CateninCell AdhesionCell Line, TumorCytoskeletonHumansActinsalpha Catenin

Identifiers

PMID26192076
PMCPMC4648412
OpenAlexW2271849284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.